Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2009-05-27
2011-10-18
Aeder, Sean (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
08039603
ABSTRACT:
A novel gene (designated 121P1F1) and its encoded protein, and variants thereof, are described wherein 121P1F1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 121P1F1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 121P1F1 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 121P1F1 can be used in active or passive immunization.
REFERENCES:
patent: 6262333 (2001-07-01), Endege et al.
patent: 6342219 (2002-01-01), Thorpe et al.
patent: 6569662 (2003-05-01), Tang et al.
patent: 6639063 (2003-10-01), Edwards et al.
patent: 6924358 (2005-08-01), Challita-Eid et al.
patent: 7601825 (2009-10-01), Challita-Eid et al.
patent: 2003/0032087 (2003-02-01), Challita-Eid et al.
patent: 2003/0223997 (2003-12-01), Challita-Eid et al.
patent: 2004/0101874 (2004-05-01), Ghosh et al.
patent: WO-99/33982 (1999-07-01), None
patent: WO-99/37771 (1999-07-01), None
patent: WO-99/38972 (1999-08-01), None
patent: WO-99/64576 (1999-12-01), None
patent: WO-00/52044 (2000-09-01), None
patent: WO-01/02568 (2001-01-01), None
patent: WO-01/22920 (2001-04-01), None
patent: WO-01/53312 (2001-07-01), None
patent: WO-01/66753 (2001-09-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/75171 (2001-10-01), None
patent: WO-02/083876 (2002-10-01), None
patent: WO-02/095009 (2002-11-01), None
Afar et al., Cancer Research (2001) 61:1686-1692.
Attwood, Science (2000) 290:471-473.
Bendayan, The Journal of Histochemistry and Cytochemistry (1995) 43(9):881-886.
Bost et al., Immunol. Invest. (1988) 17:577-586.
Burgess et al., J. Cell Biol. (1990) 111:2129-2138.
Bussemakers et al., Cancer Research (1991) 51:606-611.
Carninci et al., (1999). “High-Efficiency Full-Length cDNA Cloning” Chapter 2In cDNA Preparation and Characterization—Methods in Enzymology, Weissman, S.M. ed. Academic Press, Inc. 303:19-44.
Carninci et al., (2000). “Normalization and Subtraction of Cap-Trapper-Selected cDNAs to Prepare Full-Length cDNA Libraries for Rapid Discovery of New Genes,” Genome Research 10:1617-1630.
DGENE Record Accession No. AAX98924 for WO 99/33982, two pages, 1999.
DGENE Record Accession No. AAX99020 for WO 99/33982, two pages, 1999.
EMBL Accession No. AAM40043, created on Oct. 21, 2001, European Search Report Reference No. XP 002297423, two pages.
EMBL Accession No. AAZ80011, created on Apr. 7, 2000, European Search Report Reference No. XP 002297421, one page.
EMBL Accession No. AYO28916, created on Mar. 30, 2001, European Search Report Reference No. XP 002297424, one page.
EMBL Accession No. BE513408, created on Aug. 8, 2000, European Search Report Reference No. XP 002297422, two pages.
GenBank Accession No. AY028916 created Mar. 29, 2001, located at <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucleotide&val=13488608> last visited on Nov. 15, 2004.
GenBank Accession No. BAB27765 created on Apr. 3, 2004 located at <http://www.ncbi.nlm.nih.gov/entrez/viewe.fcgi?db=protein&val=12847934> last visited on Nov. 28, 2004, three pages.
GenBank Accession No. BE513408 created Aug. 4, 2000, located at <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucleotide&val=9720620> last visited on Nov. 15, 2004.
GenBank Accession No. NP—115493 created on Oct. 27, 2004 located at <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=14149769> last visited on Nov. 28, 2004, two pages.
Harlow et al., (1988). “Immunogenicity” Chapter 5In Antibodies, A Laboratory Manual, Cold Spring Harbor Laboratory Press, pp. 55-137.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Klein et al., Nat. Med. (1997) 3:402.
Lazar et al., Mol. Cell. Biol. (1988) 8:1247-1252.
Lerner, Nature (1982) 299:592-596.
Lewin, Genes IV, Oxford University Press (1990) p. 810.
Metzler et al., Nature Structural Biol. (1997) 4:527-531.
Mikayama et al. PNAS USA (1993) 90:10056-10060.
Ngo et al., (1994).The Protein Folding Problem and Tertiary Structure PredictionBirkhauser: Boston, MA pp. 433, 492-495.
Non-Final Office Action for U.S. Appl. No. 11/952,930, mailed on Apr. 27, 2009, 9 pages.
Office Action for Canadian Application No. 2,440,147, date mailed on Aug. 2, 2007, 6 pages.
Office Action for European Application No. 02 723 291.7, date mailed on Aug. 17, 2007, 3 pages.
Owens et al., J of Immunol Methods (1994) 168:149-165.
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Shibata et al., (2000). “RIKEN Integrated Sequence Analysis (RISA) System—384-Format Sequencing Pipeline with 384 Multicapillary Sequencer,” Genome Research 10:1757-1771.
Skolnick et al., Trends in Biotech. (2000) 18(1):34-39.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.
Supplementary Partial European Search Report mailed Oct. 6, 2004, for European Patent Application No. 02723291.7, filed Feb. 28, 2002, 7 pages.
The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team (Dec. 5, 2002). “Analysis of the Mouse Transcriptome Based on Functional Annotation of 60,770 Full-Length cDNAs,” Nature 420:563-573.
The RIKEN Genome Exploration Research Group Phase II Team and the FANTOM Consortium (Feb. 8, 2001). “Functional Annotation of a Full-Length Mouse cDNA Collection,” Nature 409:685-690.
Tsubouchi et al., (May 2002) “The Mnd1 Protein Forms a Complex with Hop2 to Promote Homologous Chromosome Pairing and Meiotic Double-Strand Break Repair,” Molecular and Cellular Biology 22(9):3078-3088.
Database UniProt, EBI accession No. UNIPROT:Q9BWT6 (2001).
Database EPO Proteins, EBI accession No. EPOP:AX974156 (2004).
European Search Report for EP 10011512.0, mailed Feb. 23, 2011, 7 pages.
Huang et al., Genomics (1999) 59(2):178-186.
Schweinfest et al., Gene Analysis Techniques (1990) 7(3):64-70.
Simpson et al., Trends in Biotechnology (2001) 19(10):S40-S48.
Ulrix et al., FEBS Letters (1999) 455(1-2):23-26.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Ge Wangmao
Hubert Rene S.
Aeder Sean
Agensys, Inc.
Morrison & Foerster / LLP
LandOfFree
Nucleic acid and corresponding protein entitled 121P1F1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and corresponding protein entitled 121P1F1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 121P1F1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301474